{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:42:01Z","timestamp":1774867321349,"version":"3.50.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.expneurol.2007.09.011","type":"journal-article","created":{"date-parts":[[2007,9,23]],"date-time":"2007-09-23T11:12:11Z","timestamp":1190545931000},"page":"89-100","source":"Crossref","is-referenced-by-count":35,"title":["In vivo gene delivery for development of mammalian models for Parkinson's disease"],"prefix":"10.1016","volume":"209","author":[{"given":"Ayse","family":"Ulusoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Bjorklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Hermening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Kirik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2007.09.011_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/104303401450988","article-title":"Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column","volume":"12","author":"Auricchio","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/mthe.2001.0462","article-title":"A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors","volume":"4","author":"Auricchio","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","article-title":"Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Bankiewicz","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/exnr.1993.1185","article-title":"Trophism, transplantation, and animal models of Parkinson's disease","volume":"124","author":"Bankiewicz","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mds.20806","article-title":"Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambui study)","volume":"21","author":"Barbosa","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.09.011_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","article-title":"DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism","volume":"24","author":"Bonifati","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modeling","volume":"60","author":"Bove","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1289\/ehp.8095","article-title":"Pesticides and Parkinson's disease\u2014is there a link?","volume":"114","author":"Brown","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.expneurol.2007.09.011_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1525-0016(02)90719-7","article-title":"A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5","volume":"6","author":"Brument","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(98)10166-6","article-title":"Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case\u2013control study. Caribbean Parkinsonism Study Group","volume":"354","author":"Caparros-Lefebvre","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2007.09.011_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","article-title":"Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe","volume":"88","author":"Champy","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.09.011_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.2004.00348.x","article-title":"Prevalence of Parkinson's disease in Sydney","volume":"111","author":"Chan","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2007.09.011_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2007.09.011_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2007.09.011_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib112","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1073\/pnas.0607260103","article-title":"DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2","volume":"103","author":"Clements","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.09.011_bib17","first-page":"77","article-title":"Oxy-radical toxicity in catecholamine neurons","volume":"5","author":"Cohen","year":"1984","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2007.09.011_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3301527","article-title":"Development of formulations that enhance physical stability of viral vectors for gene therapy","volume":"8","author":"Croyle","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2004.07.001","article-title":"Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock","volume":"121","author":"Davidoff","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.expneurol.2007.09.011_bib20","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib21","doi-asserted-by":"crossref","first-page":"12438","DOI":"10.1073\/pnas.2132992100","article-title":"Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1","volume":"100","author":"Dong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.09.011_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-510X(87)90101-8","article-title":"Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain","volume":"81","author":"Donnan","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(86)90102-8","article-title":"Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys","volume":"18","author":"Eidelberg","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.09.011_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/brain\/awl382","article-title":"Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain","volume":"130","author":"Eslamboli","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2007.09.011_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2004.07.001","article-title":"Alpha-synuclein and transgenic mouse models","volume":"17","author":"Fernagut","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.09.011_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1089\/104303400750001390","article-title":"Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo","volume":"11","author":"Gao","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng0398-262","article-title":"A susceptibility locus for Parkinson's disease maps to chromosome 2p13","volume":"18","author":"Gasser","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2007.09.011_bib30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","article-title":"A new technique for the assay of infectivity of human adenovirus 5 DNA","volume":"52","author":"Graham","year":"1973","journal-title":"Virology"},{"key":"10.1016\/j.expneurol.2007.09.011_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib32","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","article-title":"Novel tools for production and purification of recombinant adenoassociated virus vectors","volume":"9","author":"Grimm","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.gt.3300946","article-title":"Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2","volume":"6","author":"Grimm","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90295-Q","article-title":"Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons","volume":"53","author":"Hantraye","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.09.011_bib34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.21022","article-title":"Genetics of Parkinson's disease and parkinsonism","volume":"60","author":"Hardy","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(80)90871-9","article-title":"Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization","volume":"195","author":"Hefti","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2007.09.011_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jviromet.2006.03.031","article-title":"Improved high-capacity adenoviral vectors for high-level neuron-restricted gene transfer to the CNS","volume":"136","author":"Hermening","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.expneurol.2007.09.011_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.09.011_bib38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/nm964","article-title":"Local gene knockdown in the brain using viral-mediated RNA interference","volume":"9","author":"Hommel","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2007.09.011_bib39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-8993(91)90481-A","article-title":"Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum","volume":"549","author":"Ichitani","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2007.09.011_bib40","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","article-title":"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin","volume":"105","author":"Imai","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2007.09.011_bib41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jnr.10719","article-title":"Targeted transgene expression in rat brain using lentiviral vectors","volume":"73","author":"Jakobsson","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"Suppl 3","key":"10.1016\/j.expneurol.2007.09.011_bib42","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset","volume":"50","author":"Jenner","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.09.011_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1089\/104303402320139014","article-title":"Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography","volume":"13","author":"Kaludov","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib46","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib47","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.09.011_bib48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2007.09.011_bib49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/hmg\/ddl439","article-title":"Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation","volume":"16","author":"Kitao","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2007.09.011_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ymthe.2005.08.018","article-title":"Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system","volume":"12","author":"Kohlbrenner","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0963-6897(95)90031-4","article-title":"Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical, and neurochemical analysis","volume":"4","author":"Kordower","year":"1995","journal-title":"Cell Transplant"},{"key":"10.1016\/j.expneurol.2007.09.011_bib53","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.09.011_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2007.09.011_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0042-6822(03)00162-4","article-title":"Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units","volume":"311","author":"Kugler","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.expneurol.2007.09.011_bib56","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.09.011_bib57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature05290","article-title":"A century-old debate on protein aggregation and neurodegeneration enters the clinic","volume":"443","author":"Lansbury","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2007.09.011_bib58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2003.tb00035.x","article-title":"Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein","volume":"13","author":"Lauwers","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neurobiolaging.2005.12.005","article-title":"Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression","volume":"28","author":"Lauwers","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2007.09.011_bib60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2007.09.011_bib61","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.09.011_bib62","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease","volume":"101","author":"Lo Bianco","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.09.011_bib63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S1092852900010075","article-title":"Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease","volume":"10","author":"Maingay","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.expneurol.2007.09.011_bib64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nbd.2006.04.007","article-title":"Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression","volume":"23","author":"Maingay","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.09.011_bib65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","article-title":"Lack of nigrostriatal pathology in a rat model of proteasome inhibition","volume":"60","author":"Manning-Bog","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib66","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1212\/WNL.38.8.1217","article-title":"Parkinson's disease in a nationwide twin cohort","volume":"38","author":"Marttila","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2007.09.011_bib67","first-page":"588","article-title":"Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2\u201327","volume":"60","author":"Matsumine","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2007.09.011_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.09.011_bib69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.09.011_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/bp049802e","article-title":"Production of recombinant adeno-associated viral vectors using a baculovirus\/insect cell suspension culture system: from shake flasks to a 20-L bioreactor","volume":"21","author":"Meghrous","year":"2005","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.expneurol.2007.09.011_bib73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0609.2004.00290.x","article-title":"Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components","volume":"73","author":"Nakamura","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib74","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/mds.21153","article-title":"Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies","volume":"21","author":"Okubadejo","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.09.011_bib75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2007.09.011_bib76","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib77","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21\u2013q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.09.011_bib78","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.09.011_bib79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0076-6879(02)46069-7","article-title":"Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors","volume":"346","author":"Potter","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib80","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1128\/JVI.76.4.1904-1913.2002","article-title":"Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes","volume":"76","author":"Qiao","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jviromet.2006.11.019","article-title":"Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography","volume":"140","author":"Qu","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.expneurol.2007.09.011_bib82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-0934(02)00138-6","article-title":"Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR","volume":"106","author":"Rohr","year":"2002","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.expneurol.2007.09.011_bib83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2005.03.006","article-title":"Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles","volume":"127","author":"Rohr","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.expneurol.2007.09.011_bib84","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/JVI.63.9.3822-3828.1989","article-title":"Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression","volume":"63","author":"Samulski","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib85","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.09.011_bib86","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/mthe.2000.0212","article-title":"Multiplicity of infection\/multiplicity of confusion","volume":"2","author":"Shabram","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib87","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2007.09.011_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2003.09.002","article-title":"Serum-free production and column purification of adeno-associated virus type 5.","volume":"114","author":"Smith","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.expneurol.2007.09.011_bib89","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1525-0016(02)00019-9","article-title":"Quantification of adeno-associated virus particles and empty capsids by optical density measurement","volume":"7","author":"Sommer","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib90","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2007.09.011_bib91","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted overexpression of alpha-synuclein in mouse substantia nigra","volume":"100","author":"St Martin","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.09.011_bib92","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.09.011_bib93","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/10430340050015815","article-title":"Adeno-associated virus vectors show variable dependence on divalent cations for thermostability: implications for purification and handling","volume":"11","author":"Turnbull","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib95","series-title":"6-Hydroxydopamine and Catecholamine Neurons","first-page":"101","article-title":"Histochemical studies on the effects of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain","author":"Ungerstedt","year":"1971"},{"key":"10.1016\/j.expneurol.2007.09.011_bib96","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1089\/10430340260355347","article-title":"Insect cells as a factory to produce adeno-associated virus type 2 vectors","volume":"13","author":"Urabe","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib97","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.20256","article-title":"PINK1 mutations are associated with sporadic early-onset parkinsonism","volume":"56","author":"Valente","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib98","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib99","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/mthe.2002.0659","article-title":"Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks","volume":"6","author":"Veldwijk","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.33.7.815","article-title":"Parkinson's disease in 65 pairs of twins and in a set of quadruplets","volume":"33","author":"Ward","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2007.09.011_bib101","first-page":"174","article-title":"Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector","volume":"6","author":"Wright","year":"2003","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.expneurol.2007.09.011_bib102","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/JVI.61.4.972-981.1987","article-title":"Replication of adeno-associated virus in synchronized cells without the addition of a helper virus","volume":"61","author":"Yakobson","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib103","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.09.011_bib104","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2005.16.262","article-title":"Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease","volume":"16","author":"Yamada","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib105","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1073\/pnas.0404161101","article-title":"Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity","volume":"101","author":"Yao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.09.011_bib106","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuroscience.2006.09.052","article-title":"Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates","volume":"144","author":"Yasuda","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.09.011_bib107","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.011_bib108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0404.2005.00434.x","article-title":"The prevalence of PD in a nutritionally deficient rural population in China","volume":"112","author":"Zhang","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2007.09.011_bib109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/380647","article-title":"The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval","volume":"74","author":"Zimprich","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2007.09.011_bib110","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2007.09.011_bib111","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607003573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607003573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T02:46:04Z","timestamp":1708224364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488607003573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0014488607003573"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2007.09.011","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}